Colrain Capital’s AB InBev BUD Stock Holding History

Colrain Capital’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,500	Closed	-$264K	–	89
2016 Q4	$264K	Buy	2,500 +500	+25%	+$56K	0.06%	96
2016 Q3	$263K	Buy	+2,000	New	+$253K	0.06%	81

Other funds holding BUD

SCP

Soroban Capital Partners New York $47.8B AUM 11.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Colrain Capital's BUD Position: Q1 2017 in Review

Colrain Capital sold out of AB InBev (BUD) in Q1 2017, closing a stake of 2,500 shares — an estimated $264K sold.

Colrain Capital first reported a position in BUD in Q3 2016 and held it in 2 quarters. The position peaked at $264K in Q4 2016. 516 funds tracked by Wall St. Rank hold BUD as of Q1 2017.

Colrain Capital reported no remaining AB InBev position as of Q1 2017 after selling out during the quarter.
Colrain Capital sold 2,500 AB InBev shares in Q1 2017, an estimated $264K.
Colrain Capital first reported a position in AB InBev in Q3 2016 and held it in 2 quarters.
Colrain Capital's AB InBev position peaked at $264K in Q4 2016.
516 funds tracked by Wall St. Rank held AB InBev as of Q1 2017.

Based on Colrain Capital's 13F filing for Q1 2017, filed 10 May 2017.